Collapse in Rescriptor - how severe and when it was recovered? (a real world drug study)
Summary:
There is no report of severity or recovery of Collapse by people who take Rescriptor yet.
What is Rescriptor?
Rescriptor has active ingredients of delavirdine mesylate. eHealthMe is studying from 426 Rescriptor users. Check the latest studies of Rescriptor.
What is Collapse?
Collapse (sudden functional breakdown) is found to be associated with 326 drugs and 92 conditions by eHealthMe. Check the latest studies of Collapse.
No report is found.
Do you take Rescriptor and have Collapse?
Check whether Collapse is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on delavirdine mesylate (the active ingredients of Rescriptor). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ambien and Interstitial Lung Disease for Women aged 60+ - now
- Ultracet and Neutropenia for Women aged 60+ - 2 seconds ago
- Ultracet and Granulopenia for Women aged 60+ - 2 seconds ago
- Ultracet and Granulocytopenia for Women aged 60+ - 2 seconds ago
- Ultracet and Agranulocytosis for Women aged 60+ - 3 seconds ago
- Malic Acid vs. Marijuana, side effect and effectiveness comparison - 17 seconds ago
- Calan vs. Xanax, side effect and effectiveness comparison - 18 seconds ago
- Modafinil and Ibu drug interactions for women aged 40-49 - 26 seconds ago
- Drug interactions of Lenalidomide and Theophylline - 30 seconds ago
- Allopurinol and Insomnia for Men aged 30-39 - 35 seconds ago